HEATHER NOERRLINGER: Open Payments
NPI 1144879289 · SYRACUSE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 17 payments from 7 companies in 2025. Trend: 2023 $224 · 2024 $343 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 4 | $81 |
| ABBVIE INC. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: REXULTI, CAPLYTA, VRAYLAR, QULIPTA, NEXLETOL, Auvelity, BREZTRI, AIRSUPRA.
Industry payments across NE — which companies pay providers there.
